| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 11 |
| 1 | OXALIPLATIN | 8 |
| 2 | BEVACIZUMAB | 6 |
| 3 | OMEPRAZOLE MAGNESIUM | 6 |
| 4 | RISANKIZUMAB-RZAA | 6 |
| 5 | CAPECITABINE | 5 |
| 6 | ERGOCALCIFEROL | 5 |
| 7 | OMEPRAZOLE | 4 |
| 8 | UPADACITINIB | 4 |
| 9 | FOLIC ACID | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LENACAPAVIR SODIUM | 1 | 0.0020 |
| 1 | CALCIUM FOLINATE | 2 | 0.0004 |
| 2 | HYDROCORTISONE SODIUM SUCCINATE | 1 | 0.0003 |
| 3 | MIFEPRISTONE | 1 | 0.0002 |
| 4 | ERGOCALCIFEROL | 5 | 0.0002 |
| 5 | MESNA INJECTION | 1 | 0.0001 |
| 6 | MESNA | 1 | 0.0001 |
| 7 | OXALIPLATIN | 8 | 0.0001 |
| 8 | ASFOTASE ALFA | 1 | 0.0001 |
| 9 | BRENTUXIMAB VEDOTIN | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 1 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 2 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 3 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 4 | CD30-directed Immunoconjugate [EPC] | 1 | 0.0001 |
| 5 | Interleukin-23 Antagonist [EPC] | 6 | 0.0001 |
| 6 | Bile Acid [EPC] | 1 | 0.0000 |
| 7 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 6 | 0.0000 |
| 8 | Platinum-based Drug [EPC] | 8 | 0.0000 |
| 9 | Penem Antibacterial [EPC] | 1 | 0.0000 |